Oct 2026· Archives of Osteoporosis· Vol 21· 0 citations· 39 references
Medicine
TL;DR
This systematic review of eight randomized controlled trials evaluating dual-energy X-ray absorptiometry (DXA)-derived bone mineral density reports findings separately for each agent, without pooling, because the trials evaluated four pharmacologically distinct agents differing markedly in weight-lowering potency.
BACKGROUND
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve cardiometabolic outcomes, but their isolated effects on human bone remodeling remain uncertain because prior syntheses pooled heterogeneous study designs and active antidiabetic comparators. This systematic review and meta-analysis quantified the e...
M. Safargar, Navid Ahmadi, K. Prabahar et al.· Bone· 0 citations
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) (GLP-1RAs) and incretin-based multiagonist therapies have become among the most widely prescribed medications for obesity and type 2 diabetes mellitus (T2DM) management, producing clinically meaningful reductions in body weight and fat mass (FM). Concerns have e...
Amanda Palmieri Ataei, Nima Ataei· Journal of Fitness, Wellness...· 0 citations
Summary Background Obesity and hypertension frequently coexist, and weight-reduction is recommended as a core strategy for blood pressure (BP) management in adults with overweight or obesity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and emerging multi-hormone receptor modulators (MHRMs) induce substantial w...
Massimo Nardone, L. Kugathasan, L. Daunt et al.· EClinicalMedicine· 0 citations
GLP-1 receptor agonists (GLP-1RAs), dual GLP-1/GIP agonists, and the more recent triple GLP-1/GIP/glucagon agonists have transformed the treatment of type 2 diabetes mellitus (T2DM) and obesity, resulting in significant weight reduction. However, a substantial proportion (20–40%) of this weight loss is attributable to...
D. Cautela, Valeria Incarbona, A. Lombardi et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.